Tyers Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Tyers Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$5.18M	Buy	40,416 +4,752	+13%	+$637K	0.17%	113
2019 Q2	$5.08M	Buy	35,664 +2,208	+7%	+$297K	0.17%	117
2019 Q1	$4.78M	Buy	33,456 +13,632	+69%	+$1.78M	0.17%	122
2018 Q4	$2.46M	Buy	19,824 +18,800	+1,836%	+$2.79M	0.1%	174
2018 Q3	$172K	Buy	1,024 +896	+700%	+$154K	0.01%	783
2018 Q2	$22K	Buy	+128	New	+$20.9K	﹤0.01%	948

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Tyers Asset Management's JAZZ Position: Q3 2019 in Review

Tyers Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 13% in Q3 2019, buying an estimated $637K and bringing the position to 40,416 shares worth $5.18M. The position accounts for 0.17% of the portfolio, ranked #113.

Tyers Asset Management first reported a position in JAZZ in Q2 2018 and has held it in 6 quarters since. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

Tyers Asset Management held 40,416 shares of Jazz Pharmaceuticals worth $5.18M as of Q3 2019.
Tyers Asset Management bought 4,752 Jazz Pharmaceuticals shares in Q3 2019, an estimated $637K.
Jazz Pharmaceuticals made up 0.17% of Tyers Asset Management's portfolio in Q3 2019, its #113 holding.
Tyers Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and has held it in 6 quarters since.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.